EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieZurückgezogene Publikation

RETRACTED: Effects of different antihypertensive drug classes on central and ambulatory blood pressure in resistant hypertension: A randomized clinical trial

Juan Carlos Yugar-Toledo, Tatiana Palotta Minari iD, Priscilla Galisteu de Mello, Elizabeth do Espirito Santo Cestario, Tatiane de Azevedo Rubio, Larissa Morete Caieiro da Costa, Louise Bounalume Tácito Yugar, Luis Gustavo Sedenho-Prado, Lúcia Helena Bonalume Tacito, Luciana Neves Cosenso-Martin, André Fattori, Luciana Pellegrini Pisani und 2 weitere

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70249 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Juan Carlos Yugar-Toledo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hypertension Clinic, Department of Internal Medicine, State Medical School of São José do Rio Preto, São Paulo, Brazil. Hauptthemen laut MEDLINE: Hypertension, Antihypertensive Agents, Blood Pressure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Faculty of Medicine of São José do Rio Preto, University of Campinas, Faculdade de Medicina de São José do Rio Preto.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study compares sequential nephron blockade (SNB) and renin‐angiotensin system sequential blockade (RASSB) in patients with resistant hypertension (RHTN), evaluating central systolic pressure, arterial stiffness, pulse pressure (PP) and ambulatory blood pressure monitoring (ABPM).

Methods

Seventy‐two RHTN patients were randomly assigned to SNB (n = 35, 22 females, 13 males) or RASSB (n = 37, 22 females, 15 males). SNB included multiple diuretics (furosemide, spironolactone, hydrochlorothiazide) to enhance natriuresis and counter intra‐renal compensatory mechanisms. RASSB employed stepwise renin‐angiotensin system blockade using lisinopril, bisoprolol and losartan, even in patients already on valsartan.

Results

Office blood pressure reductions were significant in both groups ( P < 0.0001). SNB: systolic blood pressure (SBP) from 174.5 to 127.0 mmHg, diastolic blood pressure (DBP) from 105.3 to 78.11 mmHg. RASSB: SBP from 178.4 to 134.4 mmHg, DBP from 102.7 to 77.33 mmHg. ABPM confirmed 24‐h reductions ( P < 0.0001). SNB showed greater PP reduction (Δ = 22.99 vs 15.93 mmHg, P = 0.024) and central systolic pressure reduction (Δ = −10.3 vs –5.1 mmHg, P = 0.036). RASSB produced a pronounced heart rate decrease (Δ = −12.4 beats per minute, P < 0.0001). No treatment‐related discontinuations occurred.

Conclusion

SNB demonstrated superior efficacy in reducing central SBP and PP, while RASSB more effectively lowered heart rate. These distinct hemodynamic responses support individualized treatment strategies for patients with RHTN. ClinicalTrials.gov identifier: NCT02832973.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionAntihypertensive AgentsBlood PressureHumansFemaleMaleBlood Pressure Monitoring, AmbulatoryMiddle AgedAgedDiureticsRenin-Angiotensin SystemVascular StiffnessDrug Therapy, CombinationTreatment OutcomeAdultDrug ResistanceBisoprolol

Stichwörter der Autor:innen

ambulatory blood pressure monitoringarterial stiffnessbisoprololnatriuretic agentspulse pressurerenin‐angiotensin systemresistant hypertension

Substanzen

Antihypertensive AgentsDiureticsBisoprolol

Autor:innen und Institutionen

  • Hypertension Clinic, Department of Internal Medicine, State Medical School of São José do Rio Preto, São Paulo, Brazil.
  • Faculty of Medical Sciences, State University of Campinas, Brazil.
  • Endocrinology Division of the Internal Medicine Department, State Medical School of São José Rio Preto, São Paulo, Brazil.
  • Department of Bioscience, Federal University of São Paulo, Santos, SP, Brazil.

ORCID-Profile: Tatiana Palotta Minari

Förderung

  • Faculty of Medicine of São José do Rio Preto
  • University of Campinas
  • Faculdade de Medicina de São José do Rio Preto
  • Universidade Estadual de Campinas

Zitieren

APA

Yugar-Toledo, J. C., Minari, T. P., de Mello, P. G., do Espirito Santo Cestario, E., de Azevedo Rubio, T., da Costa, L. M. C., Yugar, L. B. T., Sedenho-Prado, L. G., Tacito, L. H. B., Cosenso-Martin, L. N., Fattori, A., Pisani, L. P., Vilela-Martin, J. F., & Moreno, H. (2026). RETRACTED: Effects of different antihypertensive drug classes on central and ambulatory blood pressure in resistant hypertension: A randomized clinical trial. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70249

Vancouver

Yugar-Toledo JC, Minari TP, de Mello PG, do Espirito Santo Cestario E, de Azevedo Rubio T, da Costa LMC, et al. RETRACTED: Effects of different antihypertensive drug classes on central and ambulatory blood pressure in resistant hypertension: A randomized clinical trial. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70249

BibTeX
@article{YugarToledo2026,
  author = {Yugar-Toledo, Juan Carlos and Minari, Tatiana Palotta and de Mello, Priscilla Galisteu and do Espirito Santo Cestario, Elizabeth and de Azevedo Rubio, Tatiane and da Costa, Larissa Morete Caieiro and Yugar, Louise Bounalume Tácito and Sedenho-Prado, Luis Gustavo and Tacito, Lúcia Helena Bonalume and Cosenso-Martin, Luciana Neves and Fattori, André and Pisani, Luciana Pellegrini and Vilela-Martin, José Fernando and Moreno, Heitor},
  title = {RETRACTED: Effects of different antihypertensive drug classes on central and ambulatory blood pressure in resistant hypertension: A randomized clinical trial},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70249}
}
Kostenlos starten →